Evidence map›Paper›PMID 39083418›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Structural basis for mouse receptor recognition by bat SARS2-like coronaviruses.

Wei Zhang, Ke Shi, Fu-Chun Hsueh, Alise Mendoza, Gang Ye, Linfen Huang, Stanley Perlman, Hideki Aihara, Fang Li

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wei Zhang *Department of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455.ORCID 0000-0003-3938-1245
Ke Shi *Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455.ORCID 0000-0003-4175-3714
Fu-Chun HsuehDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455.ORCID 0000-0002-4319-6600
Alise MendozaDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455.ORCID 0000-0003-2966-8031
Gang YeDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455.ORCID 0000-0001-6034-2174
Linfen HuangDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455.ORCID 0009-0006-4543-1316
Stanley PerlmanDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242.ORCID 0000-0003-4213-2354
Hideki AiharaDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455.ORCID 0000-0001-7508-6230
Fang LiDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, MN 55455.ORCID 0000-0002-1958-366X

Funding

User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI Nozomi Ando, J Christopher Fromme · 2018 to 2026
$34.2M
Mechanisms of MERS-CoV Entry, Cross-species Transmission and PathogenesisR01AI110700 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S, LI, FANG · 2015 to 2024
$7.4M
Structural studies of viral replication and invasionR35GM118047 · NIGMS · UNIVERSITY OF MINNESOTA · PI Hideki Aihara · 2016 to 2026
$6.3M
Receptor recognition mechanisms of coronavirusesR01AI089728 · NIAID · UNIVERSITY OF MINNESOTA · PI Fang Li, Timothy Patrick Sheahan · 2010 to 2026
$4.7M
Biacore T200 surface plasmon resonance instrumentS10OD021539 · OD · UNIVERSITY OF MINNESOTA · PI HAWKINSON, JON E · 2016 to 2016
$344k
HHS | National Institutes of Health (NIH) R01AI089728HHS | National Institutes of Health (NIH) R01AI110700HHS | National Institutes of Health (NIH) R35GM118047NIAID NIH HHS R01 AI089728NIAID NIH HHS R01 AI110700NIGMS NIH HHS P30 GM124165NIGMS NIH HHS R35 GM118047NIH HHS S10 OD021539
6 · The paper itself

Abstract

The animal origin of SARS-CoV-2 remains elusive, lacking a plausible evolutionary narrative that may account for its emergence. Its spike protein resembles certain segments of BANAL-236 and RaTG13, two bat coronaviruses considered possible progenitors of SARS-CoV-2. Additionally, its spike contains a furin motif, a common feature of rodent coronaviruses. To explore the possible involvement of rodents in the emergence of SARS-CoV-2 spike, we examined the crystal structures of the spike receptor-binding domains (RBDs) of BANAL-236 and RaTG13 each complexed with mouse receptor ACE2. Both RBDs have residues at positions 493 and 498 that align well with two virus-binding hotspots on mouse ACE2. Our biochemical evidence supports that both BANAL-236 and RaTG13 spikes can use mouse ACE2 as their entry receptor. These findings point to a scenario in which these bat coronaviruses may have coinfected rodents, leading to a recombination of their spike genes and a subsequent acquisition of a furin motif in rodents, culminating in the emergence of SARS-CoV-2.

Indexed as

Angiotensin-Converting Enzyme 2ChiropteraSARS-CoV-2Spike Glycoprotein, CoronavirusAnimalsCoronavirusCOVID-19Crystallography, X-RayHumansMiceModels, MolecularProtein BindingReceptors, VirusAce2 protein, mouseAngiotensin-Converting Enzyme 2Receptors, VirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2angiotensin-converting enzyme 2 (ACE2)receptor-binding domain (RBD)SARS-CoV-2spike proteinX-ray crystallography

Identifiers

PMID39083418
PMCPMC11317568

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.